V950

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for V950, covering 2012-12-18 to 2012-12-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study of V950 in People With Alzheimer Disease (V950-001 AM7) [Phase 1]